ANX005: Clinical Trials

3 trials of ANX005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow ANX005: new trials by email Literature Review of ANX005 trials Research Report on ANX005

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
ANX005 - Warm Autoimmune Hemolytic Anemia (wAIHA)
Phase 2CompletedAnnexon, Inc.72021-11-102026-06-30
Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)
ANX005 - Amyotrophic Lateral Sclerosis
Phase 2CompletedAnnexon, Inc.172021-01-152025-01-06
An Open Label Study of ANX005 in Participants With, or at Risk for, Manifest Huntington's Disease
ANX005 - Huntington Disease
Phase 2CompletedAnnexon, Inc.282020-09-292026-08-25

Conditions studied

Amyotrophic Lateral Sclerosis (1)  ·  Huntington Disease (1)

Sponsors

Annexon, Inc. (3)

Countries

United States (3)  ·  Australia (1)  ·  Austria (1)  ·  Bulgaria (1)  ·  Canada (1)

Top investigators

Benjamin Hoehn, MD (1)  ·  Benjamin Hoehn, MD, PhD (1)